This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Legacy Project
hanc-legacyproject.bsky.social
did:plc:s5qqr2iokpfxdhp4ywo7vyg2
GOOD NEWS!
Lenacapavir joins the CDC's current Clinical Guidance for PrEP which recommends daily oral pills or injectable cabotegravir (administered every two months). All FDA-approved PrEP options are highly effective in preventing HIV when taken as prescribed.
https://www.hiv.gov/blog/cdc-recommends-new-injectable-hiv-prep
2025-09-22T18:53:48.104Z